Amicus Therapeutics
FOLD
#3356
Rank
$4.49 B
Marketcap
$14.34
Share price
-0.07%
Change (1 day)
53.53%
Change (1 year)

Amicus Therapeutics (FOLD) Fails to deliver data

Key failure to deliver metrics for Amicus Therapeutics :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Amicus Therapeutics (FOLD) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Amicus Therapeutics (FOLD) - since 2013

Volume in USD (price x number of shares), data since 2013

Amicus Therapeutics (FOLD) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2026$2.8 M-84.32%
2025$17.89 M205.88%
2024$5.85 M56.18%
2023$3.74 M-55.9%
2022$8.49 M17.92%
2021$7.2 M-82.17%
2020$40.39 M-25.02%
2019$53.87 M65.54%
2018$32.54 M14.55%
2017$28.41 M-25.82%
2016$38.3 M-25.86%
2015$51.66 M162.72%
2014$19.66 M1873.58%
2013$0.99 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Novo Nordisk
NVO
$0.11 B$0.43 B๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Biogen
BIIB
$3.43 M$74.8 M๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
$23.88 M$0.36 B๐Ÿ‡ฌ๐Ÿ‡ง UK
Lexicon Pharmaceuticals
LXRX
$1.32 M$11.93 M๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
$3.5 M$7.97 M๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
$8.07 M$14.34 M๐Ÿ‡บ๐Ÿ‡ธ USA